Disease progression following radical prostatectomy in men with Gleason score 7 tumor

Journal of Urology

Volumn 160, Issue 1, 1998, Pages 97-101

  Epstein, J I ^a   Pound, C R ^a   Partin, A W ^a   Walsh, P C ^a   Blute, M L ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Prostatectomy; Prostatic neoplasms; Radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; DISEASE COURSE; FOLLOW UP; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; SCORING SYSTEM;

EID: 0032323451     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63045-3     Document Type: Article

References (12)

1. Epstein J.I. Partin A.W. Sauvageot J. Walsh P.C. Prediction of progression following radical prostatectomy: a multivariate analysis of 721 men with long-term follow-up. Amer. J. Surg. Path. 20 1996 286
2. Epstein J.I. Pizov G. Walsh P.C. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 71 1993 3582
3. Walsh P.C. Radical retropubic prostatectomy. 6th ed. P.C. Walsh A.B. Retik T.A. Stamey E.D. Vaughan Jr. Campbell's Urology vol. 3 1992 W. B. Saunders Co. Philadelphia 2865 2886 chapt 78
4. Bova G.S. Fox W.M. Epstein J.I. Methods of radical prostatectomy specimen processing: a novel technique for harvesting fresh prostate cancer tissue and review of processing techniques. Mod. Path. 6 1993 201
5. Hall G.S. Kramer C.E. Epstein J.I. Evaluation of radical prostatectomy specimens: a comparative analysis of various sampling methods. Amer. J. Surg. Path. 16 1992 315
6. Sanda M.G. Ayyagari S.R. Jaffe E.M. Epstein J.I. Clift S.L. Cohen L.K. Dranoff G. Pardoll D.M. Mulligan R.C. Simons J.W. Demonstration of a rational strategy for human prostate cancer gene therapy. J. Urol. 151 1994 622
7. Larsen M.P. Carter H.B. Epstein J.I. Can stage A1 tumor extent be predicted by transurethral resection tumor volume, per cent, or grade? A study of 64 stage A1 radical prostatectomies with comparison to prostates removed for stage A2 and B disease. J. Urol. 146 1991 1059
8. Kupelian P. Katcher J. Levin H. Zippe C. Klein E. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer Urology 48 1996 249
9. Oefelein M.G. Grayhack J.T. McVary K.T. Survival after radical retropubic prostatectomy of men with clinically localized high grade carcinoma of the prostate. Cancer 76 1995 2535
10. D' Amico A.V. Whittington R. Malkowicz S.B. Schultz D. Schnall M. Tomaszewski J.E. Wein A. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer J. Urol. 154 1995 131
11. Ohori M. Wheeler T.M. Kattan M.W. Goto Y. Scardino P.T. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J. Urol. 154 1995 1818
12. Lerner S.E. Blute M.L. Bergstralh E.J. Bostwick D.G. Eickholt J.T. Zincke H. Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. J. Urol. 156 1996 137